Literature DB >> 9365763

Mucosal abnormalities in microsporidiosis.

W Schmidt1, T Schneider, W Heise, J D Schulzke, T Weinke, R Ignatius, R L Owen, M Zeitz, E O Riecken, R Ullrich.   

Abstract

OBJECTIVE: To determine the prevalence of microsporidiosis in HIV-infected patients with and without diarrhoea and to characterize alterations in mucosal architecture and brush border enzyme activities in patients with microsporidiosis. PATIENTS: A total of 259 HIV-infected patients undergoing oesophago-gastroduodenoscopy because of diarrhoea (n = 123) or other symptoms (n = 136) were studied.
METHODS: Patients were evaluated for the presence of microsporidia by electron microscopy of duodenal biopsies. Brush border enzyme activities were measured by histochemistry and mucosal architecture was determined by three-dimensional morphometry in biopsies from patients with microsporidiosis and compared with biopsies from a subgroup of HIV-infected patients with or without other enteropathogens.
RESULTS: Enterocytozoon bieneusi was detected in 17 patients and Encephalitozoon intestinalis was detected in two patients. Microsporidiosis was significantly more frequent in patients with chronic diarrhoea (19.1%; P < 0.0001) or in patients with acute diarrhoea (7.2%; P = 0.04) than in patients without diarrhoea (1.5%). Microsporidiosis was associated with lactase deficiency (P = 0.03) and a reduced activity of alkaline phosphatase (P = 0.028) and alpha-glucosidase (P = 0.025) at the basal part of the villus compared with brush border enzymes in patients without enteropathogens. Patients with microsporidia had reduced villus height (P = 0.043) and a villus surface reduced by 40% (P = 0.004) compared with patients with enteropathogens other than microsporidia.
CONCLUSIONS: Our study confirms the association between microsporidia and diarrhoea. The pathophysiologic mechanism by which microsporidia cause diarrhoea appears in part to be malabsorption, caused by a reduction of absorptive mucosal surface and impairment of enterocyte function.

Entities:  

Mesh:

Year:  1997        PMID: 9365763     DOI: 10.1097/00002030-199713000-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

Review 1.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Unapparent microsporidial infection among immunocompetent humans in the Czech Republic.

Authors:  Bohumil Sak; Daniel Brady; Markéta Pelikánová; Dana Květoňová; Michael Rost; Martin Kostka; Věra Tolarová; Zuzana Hůzová; Martin Kváč
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

Review 3.  Lack of in vitro antimicrosporidian activity of thalidomide.

Authors:  O Ridoux; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

Review 4.  Small intestine pathogens in AIDS: conventional and opportunistic.

Authors:  J Koch; R L Owen
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-10

5.  Epidemiology of Enterocytozoon bieneusi Infection in Humans.

Authors:  Olga Matos; Maria Luisa Lobo; Lihua Xiao
Journal:  J Parasitol Res       Date:  2012-10-03

6.  Microsporidiosis and malnutrition in children with persistent diarrhea, Uganda.

Authors:  Siobhan M Mor; James K Tumwine; Elena N Naumova; Grace Ndeezi; Saul Tzipori
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

7.  Spectrum of chronic small bowel diarrhea with malabsorption in Indian subcontinent: is the trend really changing?

Authors:  Nirav Pipaliya; Meghraj Ingle; Chetan Rathi; Prateik Poddar; Nilesh Pandav; Prabha Sawant
Journal:  Intest Res       Date:  2016-01-26

8.  Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study.

Authors:  Elizabeth T Rogawski; Jie Liu; James A Platts-Mills; Furqan Kabir; Paphavee Lertsethtakarn; Mery Siguas; Shaila S Khan; Ira Praharaj; Arinao Murei; Rosemary Nshama; Buliga Mujaga; Alexandre Havt; Irene A Maciel; Darwin J Operario; Mami Taniuchi; Jean Gratz; Suzanne E Stroup; James H Roberts; Adil Kalam; Fatima Aziz; Shahida Qureshi; M Ohedul Islam; Pimmada Sakpaisal; Sasikorn Silapong; Pablo P Yori; Revathi Rajendiran; Blossom Benny; Monica McGrath; Jessica C Seidman; Dennis Lang; Michael Gottlieb; Richard L Guerrant; Aldo A M Lima; Jose Paulo Leite; Amidou Samie; Pascal O Bessong; Nicola Page; Ladaporn Bodhidatta; Carl Mason; Sanjaya Shrestha; Ireen Kiwelu; Estomih R Mduma; Najeeha T Iqbal; Zulfiqar A Bhutta; Tahmeed Ahmed; Rashidul Haque; Gagandeep Kang; Margaret N Kosek; Eric R Houpt
Journal:  Lancet Glob Health       Date:  2018-10-01       Impact factor: 26.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.